MICHAEL MCCANN: Open Payments
NPI 1437859923 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 23 payments from 8 companies in 2025. Trend: 2023 $340 · 2024 $331 · 2025 $655
Food & beverage: $555Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $169 |
| UCB, Inc. | 4 | $109 |
| ABBVIE INC. | 4 | $96 |
| GENZYME CORPORATION | 2 | $88 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $60 |
| Amgen Inc. | 2 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Botanix SB Inc | 2 | $36 |
Products named: TREMFYA, Bimzelx, DUPIXENT, ILUMYA, RINVOQ, Otezla, SKYRIZI, SOFDRA.
Industry payments across NC — which companies pay providers there.
